Revisiting the risks involved in using homograft ossicles in otological surgery

Journal of Laryngology and Otology

Volumn 122, Issue 2, 2008, Pages 111-115

  Lubbe, D ^a   Fagan, J J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Auditory Ossicles; Creutzfeldt Jakob Syndrome; Homologous Transplantation; Otologic Surgical Procedures

Indexed keywords

ADULT; ALLOGRAFT; ALLOTRANSPLANTATION; AUDITORY OSSICLE; CASE REPORT; CLINICAL PROTOCOL; CREUTZFELDT JAKOB DISEASE; DISINFECTION; DURA MATER; EAR RECONSTRUCTION; EAR SURGERY; EARDRUM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERICARDIUM; PROSTHESIS; REVIEW; RISK ASSESSMENT; SOUTH AFRICA; SURGICAL APPROACH; SURGICAL TECHNIQUE; VIRUS INACTIVATION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; INSTRUMENT STERILIZATION; MALE; METHODOLOGY; MIDDLE EAR RECONSTRUCTION; RISK FACTOR; TRANSPLANTATION; TREATMENT OUTCOME;

CREUTZFELDT-JAKOB SYNDROME; EAR OSSICLES; FEMALE; HIV INFECTIONS; HUMANS; MALE; OSSICULAR REPLACEMENT; RISK FACTORS; SOUTH AFRICA; STERILIZATION; TREATMENT OUTCOME;

EID: 41449106207     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107000795     Document Type: Review

References (33)

1. Chalat NI. Tympanic membrane transplant. Harper Hosp Bull 1964;22:27-34
2. Centers for Disease Control. Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura matter graft. JAMA 1987;258:309-310
3. Prichard J, Thandani V, Kalb R, Manuelidis E, Hadler J. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. Morbidity and Mortality Weekly Report 1987;34:49-55
4. Government News Network. http://www.gnn.gov.uk/environment/fullDetail. asp?Re leaseID=254733&NewsAreaID= 2&NavigatedFromDepartment=False [16 September 2007]
5. Anonymous. Round Table Discussion, Over Creutzfeldt-Jacob disease. J Jpn Med Assoc 1997;117:2015
6. Tange RA, Troost D, Limburg M. Progressive fatal dementia in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Otorhinolaryngol 1990;247:199-201
7. Bingham B. New variant CJD-BSE: the need for disposable ENT instruments. Int J Pediatr Otorhinolaryngol 2002;62:203-6
8. Mehanna H, Rejali D, Murray A. Suspending tonsillectomy: the effects on primary and secondary acute care in Scotland. Scott Med J 2004;49:144-5
9. European Group on Ethics in Science and New Technologies. http://ec.europa.eu/european_group_ethics/docs/avis11_en.pdf [16 September 2007]
10. Bauer M. Ossiculoplasty: autogenous bone grafts, 34 years experience. Clin Otolarynogol 2000;25:257-63
11. Doerr HW, Cinatl J, Stürmer M, Rabenau HF. Prions and orthopedic surgery. Infection 2003;3:163-70
12. The National Prion Disease Pathology Surveillance Center. http://www.cjdsurveillance.com [16 September 2007]
13. Minatogawa T, Kumoi T. Problems in utility and safety of otological allografts. Transplant Proc 1999;31:2036-7
14. Lang CJG, Heckmann G, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 1998;160:112-39
15. Anonymous. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan 1979-2003. Morbidity and Mortality Weekly Report 2003;52:1179-81
16. Toovey S, Britz M, Hewlett R. A case of dura mater graft-associated Creutzfeldt-Jakob disease in South Africa. S Afr Med J 2006;96:7
17. Nunery WR. Risk of prion transmission with the use of xenografts and allografts in surgery. Ophthal Plast Reconstr Surg 2001;17:389-94
18. Dormont D. How to limit the spread of Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol 1996;17:521-8
19. Doerr HW, Cinatl J, Stürmer M, Rabenau HF. Prions and orthopedic surgery. Infection 2003;31:167-8
20. The Times, Sept 27 2004. http://www.timesonline.co.uk/tol/news/uk/health/ article466397.ece [12 July 2007]
21. Taylor DM. Inactivation of the unconventional agents of scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. J Hops Infect 1991; 18(Suppl A): 141-6. In Russel AD, Hugo WB, Ayliffe GAJ, eds. Principles and Practice of Disinfection, Preservation and Sterilization. London: Blackwell, 1999;222-36
22. Dickinson AG, Taylor DM. Resistance of scrapie agent to decontamination [Letter]. N Engl J Med 1978;229:1413-4;
23. Taylor DM. Resistance of transmissible spongiform encephalopathy agents to decontamination. In: Rabenau HF, Cinatl J, Doerr HW, eds. Prions - a Challenge for Science, Medicine and Public Health System. Contrib Microbiol. Basel: Karger, 2001;7:58-67
24. Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000;159:10-17
25. Hotz MA, Speirs AD, Oxland T, Müller M, Hämmerle C, Häusler R. Radiologic and mechanical properties of inactivated ossicle homografts. Laryngoscope 1999;109:65-9
26. Romualdeza JA, Staufferb E, Häusler R, Hotz MA. A new ossicle homograft inactivation/preservation procedure: clinical results. ORL J Otorinolaryngol Relat Spec 2005;67:34-8
27. Meylan PR, Duscher A, Mudry A, Monnier P. Risk of transmission of HIV infection during tympano-ossicular homograft: an experimental study. Laryngoscope 1996;106:334-7
28. Miman MC, Cura O, Erdem T, Kirazli T, Oztop F, Ozturan O et al. An important procedure in ossiculoplasty: autoclaving the ossicles. Rev Laryngol Otol Rhinol (Bord) 2002;123:263-6
29. Lindeque BPG, Lindeque AM, Hausner H, Le Roux TLB. Tissue banking in South Africa: a 19-year history. Cell And Tissue Banking 2005;6:65-70
30. Romanet P, Duvillard C, Delouane M. Mastoid cortical bone grafts in ossiculoplasty. Ann Otolaryngol Chir Cervicofac 2000;117:105-9
31. McGee M, Hough JV. Ossiculoplasty. Otolaryngol Clin North Am 1999;32:471-88
32. Hotz MA, Häusler RH. Ossicle homografts revisited. Laryngoscope 2003;113:1274-5
33. WHO infection control guidelines for transmissible spongiform encephalopathies; 1999 http://www.who.int/csr/resources/publications/bse/ whocdscsraph2003.pdf [23 July 2007]